Variant report
Variant | esv2362581 |
---|---|
Chromosome Location | chr3:110677151-110677576 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183741682 | chr3:110677161-110677162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs7644948 | chr3:110677170-110677171 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs13098821 | chr3:110677183-110677184 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7623064 | chr3:110677192-110677193 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs189123191 | chr3:110677199-110677200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs28454694 | chr3:110677219-110677220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146939862 | chr3:110677235-110677236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs16857483 | chr3:110677292-110677293 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs147468630 | chr3:110677338-110677339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376422689 | chr3:110677340-110677341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs386664583 | chr3:110677341-110677342 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs386664584 | chr3:110677344-110677345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs148202433 | chr3:110677345-110677346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs150568370 | chr3:110677346-110677347 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542281138 | chr3:110677350-110677351 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376194282 | chr3:110677383-110677384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370573370 | chr3:110677384-110677385 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375270057 | chr3:110677385-110677386 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368130695 | chr3:110677386-110677387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7634788 | chr3:110677390-110677391 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs7623103 | chr3:110677431-110677432 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs114866088 | chr3:110677442-110677443 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543707442 | chr3:110677443-110677444 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182811927 | chr3:110677461-110677462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547609102 | chr3:110677487-110677488 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374660382 | chr3:110677502-110677503 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs113853077 | chr3:110677504-110677505 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567013553 | chr3:110677551-110677552 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Developmental delay | 22180640 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:110670400-110682400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
2 | chr3:110674800-110684600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr3:110676400-110677400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr3:110677200-110677600 | Enhancers | Gastric | stomach |
5 | chr3:110677200-110678000 | Enhancers | HepG2 | liver |
6 | chr3:110677400-110677800 | Enhancers | Fetal Muscle Leg | muscle |
7 | chr3:110677400-110678000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |